Translational Justice in Human Gene Editing: Bringing End User Engagement and Policy Together.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Building Better Medicine: Translational Justice and the Quest for Equity in US Healthcare.The American journal of bioethics : AJOB · 2025
   Article
2. Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project.European journal of human genetics : EJHG · 2024
   Article
3. Grounded in Reality: Integrating Community Values and Priorities of End Users in Human Gene Editing.The American journal of bioethics : AJOB · 2024
   Article
4. The attitude and behaviors of the different spheres of the community of the United Arab Emirates toward the clinical utility and bioethics of secondary genetic findings: a cross-sectional study.Human genomics · 2023
   Article

Corrections and comments

• Comment on
  The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research.2023

Authors and funding

11 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as